How To Use CPT Code 82627

CPT 82627 describes the analysis of dehydroepiandrosterone-sulfate (DHEA-S), a major precursor of 17-ketosteroids that the body produces when breaking down certain hormones. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 82627?

CPT 82627 can be used to describe the quantitative analysis of dehydroepiandrosterone-sulfate (DHEA-S), which is a major precursor of 17-ketosteroids. This test is commonly performed on a serum specimen using radioimmunoassay to measure the levels of DHEA-S in the body. Clinicians order this test to evaluate adrenal hormone problems, such as delayed puberty and hirsutism. Elevated levels of DHEA-S can indicate adrenal neoplasm, ovarian disorders, Cushing’s disease, and other causes of adrenal hyperplasia.

2. Official Description

The official description of CPT code 82627 is: ‘Dehydroepiandrosterone-sulfate (DHEA-S).’ There are no additional notes provided for this code.

3. Procedure

1. The lab analyst performs a quantitative analysis of dehydroepiandrosterone-sulfate (DHEA-S) in a serum specimen.
2. The analysis is typically done using radioimmunoassay, which involves tagging a gamma-radioactive isotope to measure the levels of DHEA-S.
3. Clinicians order this test to evaluate adrenal hormone problems, such as delayed puberty and hirsutism.
4. Elevated levels of DHEA-S can indicate adrenal neoplasm, ovarian disorders, Cushing’s disease, and other causes of adrenal hyperplasia.

4. Qualifying circumstances

CPT 82627 is used when clinicians order the test to evaluate adrenal hormone problems, such as delayed puberty and hirsutism. Elevated levels of DHEA-S can indicate adrenal neoplasm, ovarian disorders, Cushing’s disease, and other causes of adrenal hyperplasia. The test is performed on a serum specimen using radioimmunoassay to measure the levels of DHEA-S.

5. When to use CPT code 82627

CPT code 82627 should be used when clinicians order the quantitative analysis of dehydroepiandrosterone-sulfate (DHEA-S) to evaluate adrenal hormone problems, such as delayed puberty and hirsutism. This code is specific to the analysis of DHEA-S and should not be used for other tests or procedures.

6. Documentation requirements

To support a claim for CPT code 82627, the documentation should include:

• Reason for ordering the test, such as delayed puberty or hirsutism
• Details of the analysis performed, including the use of radioimmunoassay
• Results of the analysis, indicating the levels of DHEA-S
• Any relevant clinical findings or diagnoses
• Signature of the clinician ordering the test

7. Billing guidelines

When billing for CPT code 82627, ensure that the test is performed to evaluate adrenal hormone problems, such as delayed puberty and hirsutism. This code should not be reported with other codes unless there are additional tests or procedures performed. It is important to follow the specific guidelines provided by the payer and use the appropriate modifiers if necessary.

8. Historical information

CPT code 82627 was added to the Current Procedural Terminology system on January 1, 1993. There have been no updates or changes to the code since its addition.

9. Examples

1. A clinician orders the quantitative analysis of dehydroepiandrosterone-sulfate (DHEA-S) to evaluate a patient with delayed puberty.
2. A patient presents with hirsutism, and the clinician orders the analysis of DHEA-S to assess adrenal hormone problems.
3. A clinician suspects adrenal neoplasm in a patient and orders the quantitative analysis of DHEA-S to confirm the diagnosis.
4. A patient with Cushing’s disease undergoes the analysis of DHEA-S to monitor the effectiveness of treatment.
5. A clinician orders the analysis of DHEA-S to evaluate a patient with ovarian disorders.
6. A patient with symptoms of adrenal hyperplasia undergoes the quantitative analysis of DHEA-S to determine the cause of the condition.
7. A clinician orders the analysis of DHEA-S to evaluate a patient with abnormal adrenal hormone levels.
8. A patient with symptoms of hormonal imbalance undergoes the quantitative analysis of DHEA-S to assess adrenal function.
9. A clinician orders the analysis of DHEA-S to evaluate a patient with suspected hormonal abnormalities.
10. A patient with symptoms of hirsutism undergoes the quantitative analysis of DHEA-S to determine the underlying cause.